Annual report

Period2021-07-01 → 2022-06-30
Filed2022-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales
Revenue¥8.9bn2020-07-01 → 2021-06-30Cons.Net sales
Revenue¥9.3bn2019-07-01 → 2020-06-30dCons.Net sales (5-year summary)
Revenue¥7.6bn2018-07-01 → 2019-06-30dCons.Net sales (5-year summary)
Revenue¥5.5bn2017-07-01 → 2018-06-30dCons.Net sales (5-year summary)
Operating income¥1.2bn2021-07-01 → 2022-06-30Cons.Operating income
Operating income¥917m2020-07-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥920m2020-07-01 → 2021-06-30Cons.Ordinary income
Ordinary income¥1.1bn2019-07-01 → 2020-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥878m2018-07-01 → 2019-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥341m2017-07-01 → 2018-06-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥1.3bn2021-07-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥908m2020-07-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥562m2020-07-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥732m2019-07-01 → 2020-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥553m2018-07-01 → 2019-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥198m2017-07-01 → 2018-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥817m2021-07-01 → 2022-06-30Cons.Profit loss
Net income¥581m2020-07-01 → 2021-06-30Cons.Profit loss
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥7.1bnat 2021-06-30Cons.Assets
Total assets¥7.4bnat 2020-06-30dCons.Total assets (5-year summary)
Total assets¥6.3bnat 2019-06-30dCons.Total assets (5-year summary)
Total assets¥5.6bnat 2018-06-30dCons.Total assets (5-year summary)
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Total liabilities¥915mat 2021-06-30Cons.Liabilities
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.2bnat 2021-06-30Cons.Net assets
Net assets / equity¥5.8bnat 2020-06-30dCons.Net assets
Net assets / equity¥5.2bnat 2019-06-30dCons.Net assets (5-year summary)
Net assets / equity¥4.6bnat 2018-06-30dCons.Net assets (5-year summary)
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥4.3bnat 2021-06-30Cons.Cash and deposits
Cash & equivalents¥6.0bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.5bnat 2020-06-30dCons.Cash and cash equivalents
Cash & equivalents¥3.1bnat 2019-06-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥3.0bnat 2018-06-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥107m2020-07-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥830m2019-07-01 → 2020-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥469m2018-07-01 → 2019-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥74m2017-07-01 → 2018-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥245m2021-07-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥25m2020-07-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥693m2019-07-01 → 2020-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥289m2018-07-01 → 2019-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥16m2017-07-01 → 2018-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥130m2021-07-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥131m2020-07-01 → 2021-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥103m2019-07-01 → 2020-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥52m2018-07-01 → 2019-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥276m2017-07-01 → 2018-06-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.492020-07-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.972019-07-01 → 2020-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.162018-07-01 → 2019-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.572017-07-01 → 2018-06-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥254.14at 2022-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥230.88at 2021-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥214.39at 2020-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥190.87at 2019-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥171.84at 2018-06-30dCons.Net assets per share (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.7%at 2020-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio79.5%at 2019-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio79.6%at 2018-06-30dCons.Equity to asset ratio (5-year summary)
ROE12.8%2021-07-01 → 2022-06-30Cons.Rate of return on equity (5-year summary)
ROE9.7%2020-07-01 → 2021-06-30Cons.Rate of return on equity (5-year summary)
ROE13.8%2019-07-01 → 2020-06-30dCons.Rate of return on equity (5-year summary)
ROE11.7%2018-07-01 → 2019-06-30dCons.Rate of return on equity (5-year summary)
ROE4.5%2017-07-01 → 2018-06-30dCons.Rate of return on equity (5-year summary)
Employees100at 2022-06-30Cons.Number of employees
Employees104at 2021-06-30Cons.Number of employees
Employees105at 2020-06-30dCons.Number of employees
Employees101at 2019-06-30dCons.Number of employees
Employees97at 2018-06-30dCons.Number of employees
Revenue¥439m2021-07-01 → 2022-06-30StandaloneNet sales
Revenue¥425m2020-07-01 → 2021-06-30StandaloneNet sales
Revenue¥425m2019-07-01 → 2020-06-30dStandaloneNet sales (5-year summary)
Revenue¥303m2018-07-01 → 2019-06-30dStandaloneNet sales (5-year summary)
Revenue¥289m2017-07-01 → 2018-06-30dStandaloneNet sales (5-year summary)
Operating income¥134m2021-07-01 → 2022-06-30StandaloneOperating income
Operating income¥130m2020-07-01 → 2021-06-30StandaloneOperating income
Ordinary income¥137m2021-07-01 → 2022-06-30StandaloneOrdinary income
Ordinary income¥132m2020-07-01 → 2021-06-30StandaloneOrdinary income
Ordinary income¥116m2019-07-01 → 2020-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥73m2018-07-01 → 2019-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥12m2017-07-01 → 2018-06-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥137m2021-07-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax¥132m2020-07-01 → 2021-06-30StandaloneIncome before income taxes
Net income¥195m2021-07-01 → 2022-06-30StandaloneProfit loss
Net income¥288m2020-07-01 → 2021-06-30StandaloneProfit loss
Net income¥155m2019-07-01 → 2020-06-30dStandaloneNet income loss (5-year summary)
Net income¥111m2018-07-01 → 2019-06-30dStandaloneNet income loss (5-year summary)
Net income¥60m2017-07-01 → 2018-06-30dStandaloneNet income loss (5-year summary)
Total assets¥4.5bnat 2022-06-30StandaloneAssets
Total assets¥4.2bnat 2021-06-30StandaloneAssets
Total assets¥4.1bnat 2020-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.0bnat 2019-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.0bnat 2018-06-30dStandaloneTotal assets (5-year summary)
Total liabilities¥196mat 2022-06-30StandaloneLiabilities
Total liabilities¥22mat 2021-06-30StandaloneLiabilities
Net assets / equity¥4.3bnat 2022-06-30StandaloneNet assets
Net assets / equity¥4.2bnat 2021-06-30StandaloneNet assets
Net assets / equity¥4.1bnat 2020-06-30dStandaloneNet assets
Net assets / equity¥4.0bnat 2019-06-30dStandaloneNet assets (5-year summary)
Net assets / equity¥4.0bnat 2018-06-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥953mat 2021-06-30StandaloneCash and deposits
EPS (basic)¥7.472021-07-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.022020-07-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.912019-07-01 → 2020-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥4.262018-07-01 → 2019-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥2.292017-07-01 → 2018-06-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥52021-07-01 → 2022-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52020-07-01 → 2021-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52019-07-01 → 2020-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥42018-07-01 → 2019-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥22017-07-01 → 2018-06-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥163.52at 2022-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥161.05at 2021-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥155.03at 2020-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥153.56at 2019-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥151.43at 2018-06-30dStandaloneNet assets per share (5-year summary)
Equity ratio95.6%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.6%at 2020-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.3%at 2019-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.0%at 2018-06-30dStandaloneEquity to asset ratio (5-year summary)
ROE4.6%2021-07-01 → 2022-06-30StandaloneRate of return on equity (5-year summary)
ROE7.0%2020-07-01 → 2021-06-30StandaloneRate of return on equity (5-year summary)
ROE3.8%2019-07-01 → 2020-06-30dStandaloneRate of return on equity (5-year summary)
ROE2.8%2018-07-01 → 2019-06-30dStandaloneRate of return on equity (5-year summary)
ROE1.5%2017-07-01 → 2018-06-30dStandaloneRate of return on equity (5-year summary)
Shares issued26,158,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2021-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2020-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2019-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2018-06-30dStandaloneTotal number of issued shares (5-year summary)
Employees9at 2022-06-30StandaloneNumber of employees
Employees8at 2021-06-30StandaloneNumber of employees
Employees8at 2020-06-30dStandaloneNumber of employees
Employees7at 2019-06-30dStandaloneNumber of employees
Employees5at 2018-06-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 93
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2021-07-01 → 2022-06-30¥237,000
Reconciling Itemsreconcilingrevenue2021-07-01 → 2022-06-30−¥9m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2022-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2022-06-30−¥11m
Reconciling Itemsreconcilingsegment assetsat 2022-06-30¥1.3bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2022-06-30−¥304m
Clinical Evidence Servicereportable segmentcapex2021-07-01 → 2022-06-30¥5m
Clinical Evidence Servicereportable segmentdepreciation2021-07-01 → 2022-06-30¥2m
Clinical Evidence Servicereportable segmentemployeesat 2022-06-3023 pure
Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2022-06-30¥552m
Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2022-06-30¥552m
Clinical Evidence Servicereportable segmentsegment assetsat 2022-06-30¥453m
Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2022-06-30¥6m
Functional Cosmetic Retailingreportable segmentcapex2021-07-01 → 2022-06-30¥5m
Functional Cosmetic Retailingreportable segmentdepreciation2021-07-01 → 2022-06-30¥11m
Functional Cosmetic Retailingreportable segmentemployeesat 2022-06-3028 pure
Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2022-06-30¥5.0bn
Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2022-06-30¥5.0bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2022-06-30¥3.7bn
Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2022-06-30¥1.1bn
Functional Food Retailingreportable segmentcapex2021-07-01 → 2022-06-30¥34m
Functional Food Retailingreportable segmentdepreciation2021-07-01 → 2022-06-30¥3m
Functional Food Retailingreportable segmentemployeesat 2022-06-3023 pure
Functional Food Retailingreportable segmentrevenue2021-07-01 → 2022-06-30¥2.7bn
Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2022-06-30¥2.7bn
Functional Food Retailingreportable segmentsegment assetsat 2022-06-30¥1.3bn
Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2022-06-30¥200m
Functional Material Developmentreportable segmentdepreciation2021-07-01 → 2022-06-30¥2m
Functional Material Developmentreportable segmentemployeesat 2022-06-3010 pure
Functional Material Developmentreportable segmentrevenue2021-07-01 → 2022-06-30¥569m
Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2022-06-30¥558m
Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2022-06-30¥11m
Functional Material Developmentreportable segmentsegment assetsat 2022-06-30¥1.3bn
Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2022-06-30¥83m
Health Care Support Servicereportable segmentcapex2021-07-01 → 2022-06-30¥709,000
Health Care Support Servicereportable segmentdepreciation2021-07-01 → 2022-06-30¥1m
Health Care Support Servicereportable segmentemployeesat 2022-06-307 pure
Health Care Support Servicereportable segmentrevenue2021-07-01 → 2022-06-30¥549m
Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2022-06-30¥549m
Health Care Support Servicereportable segmentsegment assetsat 2022-06-30¥330m
Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2022-06-30¥117m
—segment totalcapex2021-07-01 → 2022-06-30¥45m
—segment totaldepreciation2021-07-01 → 2022-06-30¥20m
—segment totalrevenue2021-07-01 → 2022-06-30¥9.4bn
—segment totalrevenue external2021-07-01 → 2022-06-30¥9.3bn
—segment totalrevenue intersegment2021-07-01 → 2022-06-30¥11m
—segment totalsegment assetsat 2022-06-30¥7.2bn
—segment totalsegment profit2021-07-01 → 2022-06-30¥1.5bn
Reconciling Itemsreconcilingcapex2020-07-01 → 2021-06-30¥245,000
Reconciling Itemsreconcilingdepreciation2020-07-01 → 2021-06-30¥508,000
Reconciling Itemsreconcilingrevenue2020-07-01 → 2021-06-30−¥25m
Reconciling Itemsreconcilingrevenue external2020-07-01 → 2021-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2020-07-01 → 2021-06-30−¥26m
Reconciling Itemsreconcilingsegment assetsat 2021-06-30¥1.2bn
Reconciling Itemsreconcilingsegment profit2020-07-01 → 2021-06-30−¥293m
Clinical Evidence Servicereportable segmentcapex2020-07-01 → 2021-06-30¥14m
Clinical Evidence Servicereportable segmentdepreciation2020-07-01 → 2021-06-30¥6m
Clinical Evidence Servicereportable segmentrevenue2020-07-01 → 2021-06-30¥553m
Clinical Evidence Servicereportable segmentrevenue external2020-07-01 → 2021-06-30¥536m
Clinical Evidence Servicereportable segmentrevenue intersegment2020-07-01 → 2021-06-30¥17m
Clinical Evidence Servicereportable segmentsegment assetsat 2021-06-30¥454m
Clinical Evidence Servicereportable segmentsegment profit2020-07-01 → 2021-06-30−¥31m
Functional Cosmetic Retailingreportable segmentcapex2020-07-01 → 2021-06-30¥8m
Functional Cosmetic Retailingreportable segmentdepreciation2020-07-01 → 2021-06-30¥13m
Functional Cosmetic Retailingreportable segmentrevenue2020-07-01 → 2021-06-30¥4.4bn
Functional Cosmetic Retailingreportable segmentrevenue external2020-07-01 → 2021-06-30¥4.4bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2021-06-30¥2.6bn
Functional Cosmetic Retailingreportable segmentsegment profit2020-07-01 → 2021-06-30¥777m
Functional Food Retailingreportable segmentcapex2020-07-01 → 2021-06-30¥284,000
Functional Food Retailingreportable segmentdepreciation2020-07-01 → 2021-06-30¥3m
Functional Food Retailingreportable segmentrevenue2020-07-01 → 2021-06-30¥2.7bn
Functional Food Retailingreportable segmentrevenue external2020-07-01 → 2021-06-30¥2.7bn
Functional Food Retailingreportable segmentsegment assetsat 2021-06-30¥1.3bn
Functional Food Retailingreportable segmentsegment profit2020-07-01 → 2021-06-30¥221m
Functional Material Developmentreportable segmentdepreciation2020-07-01 → 2021-06-30¥3m
Functional Material Developmentreportable segmentrevenue2020-07-01 → 2021-06-30¥807m
Functional Material Developmentreportable segmentrevenue external2020-07-01 → 2021-06-30¥798m
Functional Material Developmentreportable segmentrevenue intersegment2020-07-01 → 2021-06-30¥9m
Functional Material Developmentreportable segmentsegment assetsat 2021-06-30¥1.4bn
Functional Material Developmentreportable segmentsegment profit2020-07-01 → 2021-06-30¥171m
Health Care Support Servicereportable segmentcapex2020-07-01 → 2021-06-30¥339,000
Health Care Support Servicereportable segmentdepreciation2020-07-01 → 2021-06-30¥1m
Health Care Support Servicereportable segmentrevenue2020-07-01 → 2021-06-30¥451m
Health Care Support Servicereportable segmentrevenue external2020-07-01 → 2021-06-30¥451m
Health Care Support Servicereportable segmentsegment assetsat 2021-06-30¥249m
Health Care Support Servicereportable segmentsegment profit2020-07-01 → 2021-06-30¥72m
—segment totalcapex2020-07-01 → 2021-06-30¥23m
—segment totaldepreciation2020-07-01 → 2021-06-30¥27m
—segment totalrevenue2020-07-01 → 2021-06-30¥9.0bn
—segment totalrevenue external2020-07-01 → 2021-06-30¥8.9bn
—segment totalrevenue intersegment2020-07-01 → 2021-06-30¥26m
—segment totalsegment assetsat 2021-06-30¥5.9bn
—segment totalsegment profit2020-07-01 → 2021-06-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,274
ItemContextValueUnit
Intangible assetsPrior1YearInstant29037000JPY
Intangible assetsCurrentYearInstant49290000JPY
Investment securitiesPrior1YearInstant20738000JPY
Investment securitiesCurrentYearInstant20738000JPY
Deferred tax assetsPrior1YearInstant59080000JPY
Deferred tax assetsCurrentYearInstant84986000JPY
Other ioaPrior1YearInstant102900000JPY
Other ioaCurrentYearInstant101601000JPY
Investments and other assetsPrior1YearInstant182718000JPY
Investments and other assetsCurrentYearInstant207326000JPY
Noncurrent assetsPrior1YearInstant248407000JPY
Noncurrent assetsCurrentYearInstant292992000JPY
AssetsPrior1YearInstant7146534000JPY
AssetsCurrentYearInstant8489524000JPY
Accounts payable tradePrior1YearInstant227375000JPY
Accounts payable tradeCurrentYearInstant459693000JPY
Income taxes payablePrior1YearInstant77260000JPY
Income taxes payableCurrentYearInstant291293000JPY
Provision for point card certificates clPrior1YearInstant100132000JPY
Provision for point card certificates clCurrentYearInstant-JPY
Advances receivedPrior1YearInstant245084000JPY
Advances receivedCurrentYearInstant-JPY
Contract liabilitiesPrior1YearInstant-JPY
Contract liabilitiesCurrentYearInstant534015000JPY
Other clPrior1YearInstant248339000JPY
Other clCurrentYearInstant339658000JPY
Current liabilitiesPrior1YearInstant898193000JPY
Current liabilitiesCurrentYearInstant1624660000JPY
Net defined benefit liabilityPrior1YearInstant16646000JPY
Net defined benefit liabilityCurrentYearInstant17496000JPY
Deferred tax liabilitiesPrior1YearInstant156000JPY
Deferred tax liabilitiesCurrentYearInstant-JPY
Noncurrent liabilitiesPrior1YearInstant16803000JPY
Noncurrent liabilitiesCurrentYearInstant17496000JPY
LiabilitiesPrior1YearInstant914996000JPY
LiabilitiesCurrentYearInstant1642157000JPY
Capital stockPrior1YearInstant1836587000JPY
Capital stockCurrentYearInstant1836587000JPY
Capital surplusPrior1YearInstant1899955000JPY
Capital surplusCurrentYearInstant1899955000JPY
Retained earningsPrior1YearInstant2302914000JPY
Retained earningsCurrentYearInstant2911255000JPY
Shareholders equityPrior1YearInstant6039457000JPY
Shareholders equityCurrentYearInstant6647798000JPY
Non controlling interestsPrior1YearInstant192079000JPY
Non controlling interestsCurrentYearInstant199568000JPY
Net assetsPrior1YearInstant6231537000JPY
Net assetsCurrentYearInstant6847367000JPY
Liabilities and net assetsPrior1YearInstant7146534000JPY
Liabilities and net assetsCurrentYearInstant8489524000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-06-30pass rounding
balance sheet identityconsolidated 2022-06-30pass
balance sheet identitynon_consolidated 2021-06-30pass
balance sheet identitynon_consolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-06-30pass
statement vs summary · net assetsconsolidated 2021-06-30pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsnon_consolidated 2020-06-30pass
statement vs summary · net assetsnon_consolidated 2021-06-30pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2020-07-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2020-07-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2021-07-01/2022-06-30pass
statement vs summary · revenueconsolidated 2020-07-01/2021-06-30pass
statement vs summary · revenueconsolidated 2021-07-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2020-07-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2021-07-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-06-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-06-30pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass